Targets › O2
1 program from 1 company in 1 trial: 1 Phase 3; Neurology; next expected readout Aug 2028.
Open in Phaseline: the race on O2, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| University of South Florida | Oxygen 99.7% Hyperbaric oxygen therapy (HBOT) at 2.0 ATA delivering 100% oxygen | O2 | Phase 3 | Traumatic Brain Injury | Aug 2028 |
Traumatic Brain Injury (1)
small molecule (1)
University of South Florida (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.